Analyst Ratings for Eagle Pharmaceuticals Inc. (EGRX)

Updated: 2017-07-28

An average rating of Overweight has been given to Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) by analysts covering the stock. EGRX had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 3 analysts, 0 gave an overweight rating, 0 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Many analysts weighed in on price targets for EGRX. The most optimistic price target was 118, which equates to a potential upside of 132.47 percent. The most pessimistic analyst gave a price target of 57, implying potential capital losses of 12.29 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -23.85 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -6.27 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts decreased their estimates.

EGRX has an estimated earnings growth rate of -46.64 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. People often look for the PEG ratio to be under 1, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of EGRX is -0.17.

EGRX has traded between a high of 97.15 and a low of 42.33 over the past year. The current market price is above the trailing year's low by 19.91 percent, and 47.75 percent below the high. EGRX has a price/earnings ratio of 7.87. Investors typically compare the P/E ratio to a company's peers in the industry. The EGRX value stock report compares EGRX to some of its peers using value stock charts. The stock has a market capitalization of $0.80613 billion. EGRX's next earnings release will be on 0000-00-00, which is days away.